Posted from Clinical Pharmacology &... 123 days ago
Pharmacology : Pharmacology News
Shift From Surrogate End Point to Outcome Trials: Implications for Cardiovascular Safety Assessment in Development Programs for Antidiabetic Drugs
Clinical Pharmacology & Therapeutics advance online publication, November 23, 2011.
doi:10.1038/clpt.2011.257
Authors: J F Marcinak, P Viswanathan, V Arora, L E Roebel, T R Strack
& E Leifke
(original story)